Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-585 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-585 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18 |
filingDate |
2002-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_810d4622159ea89d8eb3fdef3203c97a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f6186cc1631dcab2d3e61f7faa5cf73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcad364f39c006699fa2498f8f74bc70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_373f74155d612fea9698fb6609e9d543 |
publicationDate |
2007-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
BG-65204-B1 |
titleOfInvention |
PHARMACEUTICAL FORM, PHARMACEUTICAL FORM AND USE THEREOF AS ANTI-INFECTION |
abstract |
The invention relates to a pharmaceutical composition which contains as first active agent drospirenone from about 2 to about 4 mg corresponding to a single daily dose using the composition and as the second active agent ethinylestradiol of about 0.01 to about 0.05 mg, corresponding to the single daily dose, together with one or more pharmaceutically acceptable carriers or excipients. The invention also relates to a pharmaceutical kit comprising a plurality of individually packed individual daily doses in a single package. Part of daily dosage units contain a composition according to the invention and another part is free of active agents. The composition is used to provide a medicament for inhibiting ovulation and for the prevention and treatment of androgen-induced disorders in female mammals. |
priorityDate |
1999-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |